{"id":126168,"date":"2021-08-12T22:22:53","date_gmt":"2021-08-13T05:22:53","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/08\/msd-announces-supply-agreement-with-u-s-government-for-molnupiravir-an-investigational-oral-antiviral-candidate-for-treatment-of-mild-to-moderate-covid-19"},"modified":"2021-08-12T22:22:53","modified_gmt":"2021-08-13T05:22:53","slug":"msd-announces-supply-agreement-with-u-s-government-for-molnupiravir-an-investigational-oral-antiviral-candidate-for-treatment-of-mild-to-moderate-covid-19","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/08\/msd-announces-supply-agreement-with-u-s-government-for-molnupiravir-an-investigational-oral-antiviral-candidate-for-treatment-of-mild-to-moderate-covid-19","title":{"rendered":"MSD Announces Supply Agreement with U.S. Government for Molnupiravir, an Investigational Oral Antiviral Candidate for Treatment of Mild to Moderate COVID-19"},"content":{"rendered":"<p>U.S. government commits to purchase approximately 1.7 million courses of Molnupiravir upon issuance of Emergency Use Authorization or approval by the U.S. Food and Drug Administration.<\/p>\n<p>KENILWORTH, N.J. 0 June 17 2021 \/PRNewswire\/ \u2014 Merck (NYSE: <a class=\"\" data-toggle=\"modal\" href=\"https:\/\/www.prnewswire.com\/news-releases\/msd-announces-supply-agreement-with-us-government-for-molnupiravir-an-investigational-oral-antiviral-candidate-for-treatment-of-mild-to-moderate-covid-19-301314831.html#financial-modal\">MRK<\/a>), known as MSD outside the United States and Canada 0 today announced it has entered into a procurement agreement with the United States government for Molnupiravir (MK-4482). Molnupiravir is currently being evaluated in a Phase 3 clinical trial, the MOVe-OUT study, for the treatment of non-hospitalized patients with laboratory-confirmed COVID-19 and at least one risk factor associated with poor disease outcomes. MSD is developing Molnupiravir in collaboration with Ridgeback Biotherapeutics.<\/p>\n<p>\u201cMSD is pleased to collaborate with the U.S. government on this new agreement that will provide Americans with COVID-19 access to molnupiravir \u2013 an investigational oral therapy being studied for outpatient use early in the course of disease \u2013 if it is authorized or approved,\u201d said Rob Davis 0 president, MSD. \u201cIn addition to this agreement with the U.S. government, we are actively engaged in numerous efforts to make molnupiravir available globally to fulfill MSD\u2019s commitment to widespread access.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>U.S. government commits to purchase approximately 1.7 million courses of Molnupiravir upon issuance of Emergency Use Authorization or approval by the U.S. Food and Drug Administration. KENILWORTH, N.J. 0 June 17 2021 \/PRNewswire\/ \u2014 Merck (NYSE: MRK), known as MSD outside the United States and Canada 0 today announced it has entered into a procurement [\u2026]<\/p>\n","protected":false},"author":534,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1490],"tags":[],"class_list":["post-126168","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-government"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/126168","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/534"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=126168"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/126168\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=126168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=126168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=126168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}